Drug Discovery
Latest Content
First phase of Oxford’s new 1 million sq. ft lab district begins
Laing O’Rourke will begin the initial phase of Oxford North’s £700 million new innovation district, with the aim of completing by the second quarter of 2025.
News
First phase of Oxford’s new 1 million sq. ft lab district begins
Laing O’Rourke will begin the initial phase of Oxford North’s £700 million new innovation district, with the aim of completing by the second quarter of 2025.
In Depth
Enabling miniaturisations of automated organoid drug screens
Advanced cell-based models have grown in popularity for drug testing applications. The use of nanofibrillar cellulose hydrogels has enabled organoid drug screening that is largely animal free, automa…
Comment And Analysis
Achieving an animal free IHC
With alternative technologies available, we should be seeking antibody alternatives that avoid the unnecessary use of animals in research, urges Dr David Bunka.
Interviews
Catherine Noakes and the Scientific Advisory Group for Emergencies (SAGE)
As part of a collaborative group of six British expert scientists, Catherine Noakes will join Jonathan Van-Tam and his team for the 2021 Royal Institutions Christmas Lectures which will be recorded …
Focal Point
Chameleon embryo
This incredible image was awarded ‘Honorable Mention status in the 2018 Nikon Small World competition.
